Respiratory syncytial virus (RSV) poses a significant threat to adults at increased risk of severe disease, including older adults and those with chronic conditions. As the most accessible immunization providers, community pharmacists are well-positioned to lead RSV prevention efforts. This session will provide the latest evidence, recommendations, and practical strategies to help pharmacists confidently identify at-risk patients and integrate RSV vaccination into routine care this season.

Sponsored by GSK